State Street Corp Sarepta Therapeutics, Inc. Transaction History
State Street Corp
- $2.8 Trillion
- Q3 2025
A detailed history of State Street Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 5,304,907 shares of SRPT stock, worth $99.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,304,907
Previous 4,695,027
12.99%
Holding current value
$99.8 Million
Previous $80.3 Million
27.33%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding SRPT
# of Institutions
411Shares Held
153MCall Options Held
5.44MPut Options Held
6.09M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct68.8MShares$1.29 Billion0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$194 Million0.04% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$50.5 Million0.49% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.65MShares$49.8 Million0.07% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.65B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...